We have partially cloned and sequenced the genome of a Peruvian yellow fever virus isolate (1899/81) and compared the nucleotide and deduced amino acid sequences of this strain with the previously published sequence of the West African yellow fever virus strain Asibi. In the 3594 base region sequenced, which contains the structural genes (C, M, E), all but the 72 3'-terminal nucleotides of the NS1 gene and 108 nucleotides of the 5' non-coding region, 515 nucleotide substitutions were detected. Nucleotide divergence was lowest in the 5' non-coding region, 2-8 %, compared with an average rate of 14.7 % in the coding regions. Over 91% of the 512 nucleotide changes in the coding region were silent; 44 amino acid substitutions resulted. The capsid protein was the least conserved, whereas the M protein was the most highly conserved (6.7 % and 1-3 % divergence, respectively). The envelope protein had 18 amino acid changes (3.7 % divergence), one of which created an additional site for potential glycosylation of the 1899/81 virus. NS1 protein divergence (3-9%) was similar to that seen in the E protein. Of the 44 amino acid substitutions found, 34 (77 %) were conservative. The highest number of nonconservative differences occurred in the envelope glycoprotein. These changes may significantly affect the antigenic and biological functions of the viruses.
Introduction
Yellow fever virus (YFV) is a member of the Flavivirus genus of the family Flaviviridae. Historically, YFV caused widespread urban epidemics in the Americas, Europe and Africa. Although the use of mosquito control measures and the development of safe and effective vaccines against YFV have eradicated it from many areas of the world, the virus is still present in forested regions of Africa and South America where it is maintained in an enzootic cycle between mosquito vectors (Aedes spp. in Africa; Haemagogus spp. in S. America) and primate hosts. The continued presence of YFV in these areas creates the potential for renewed introduction of the virus into human population centres.
The conventional historical view is that YFV originated in Africa (Carter, 1931 ; Taylor, 1951) and then was disseminated to S. America via slave trading as early as the 16th century. The YFV populations on these two continents, isolated in separate ecological systems for several hundred years, have evolved under different selection pressures imposed by environment, invertebrate vectors and vertebrate hosts and evolutionary divergence in several biological and physical characteristics has been demonstrated. South American, but not African, YFV strains are virulent for 8-day-old mice following intraperitoneal inoculation (Deubel et al., 1987) . Immunochemical studies have shown antigenic differences (Clarke, 1960) , including the ability of monoclonal antibodies to distinguish between African and American strains (Deubel et al., 1987) . The envelope (E) protein of the two virus populations differs in electrophoretic mobility and carbohydrate content (Deubel et al., 1987; Cane & Gould, 1989) . Finally, genetic heterogeneity has been demonstrated between S. American and African YFV strains by oligonucleotide fingerprinting resulting in their classification into separate geographical topotypes (Deubel et al., 1986) .
The YFV genome consists of a single, positivestranded, RNA molecule (Westaway, 1980) and is subject to the high rate of mutation associated with RNA viruses (Holland et al., 1982; Reanney, 1982; Strauss & Strauss, 1988) . The sequences of the 17D vaccine and virulent Asibi YFV genomes have been determined (Rice et al., 1985; Hahn et al., 1987) . These strains, which are separated by 240 in vitro passages, differ at 68 nucleotide positions, resulting in 32 amino acid substitutions (Hahn et al., 1987) . One or more of these changes may be responsible for the avirulent phenotype of the vaccine strain, however, researchers have not correlated specific sequence differences with alterations in biological or physical characteristics.
To investigate the molecular basis for the differences observed between African and S. American YFV populations, we have cloned and sequenced the 5' one third of the genome of a Peruvian YFV isolate, 1899/81, and compared it with the African Asibi strain (Hahn et al., 1987) at both the nucleotide and amino acid levels. The results of this study may then be used in relating molecular changes to biological function of the virus proteins.
filamentous bacteriophage M 13 mp 18/19 (Yanisch-Perron et al., 1985) and overlapping deletion clones were generated using T4 DNA polymerase (Dale et al., 1985 ; Cyclone System, International Biotechnologies) . Both strands of cDNA inserts were sequenced by the dideoxynucleotide chain termination method (Sanger et aL, 1977) using DNA polymerase I Klenow fragment. Sequence compressions were resolved by sequencing with T7 DNA polymerase (Sequenase Version 2.0, U.S. Biochemical).
Results and discussion

Methods
Virus. The YFV strain sequenced, YF 1899/81-B4.1, was a plaquepurified clone of YF 1899/81, a human isolate from Peru (Mendez et al., 1984; Miller & Adkins, 1988 ) that exhibited a virulent, wild-type phenotype in mosquitoes and mice. Plaque purification was performed in Vero cells and stocks were prepared in suckling mouse brain following amplification in BHK-21 cells.
For virus purification, SW-13 cell monolayers were infected at an m.o.i, of approximately 1.0 with freshly prepared infected suckling mouse brain Stock. Culture supernatant was harvested 4 days following infection and virus was concentrated by polyethylene glycol precipitation and purified by rate-zonal and isopycnic potassium tartrate glycerol gradient centrifugation. Virions were disrupted by treatment with proteinase K (0.2 mg/ml, 37 °C, 20 min) and SDS (1.0%, 37 °C, 20 min), after which viral RNA was extracted with phenol/chloroform/ isoamyl alcohol (25:24:1) (Trent et aL, 1979) .
Radioimmunoprecipitation (RIP) assay. 35S-labelled cell lysates were prepared according to a modification of the method of Schlesinger et al. (1983) . Vero cells were infected with YF 1899/81-B4.1 or YFV Asibi at an m.o.i, of approximately 5.0 or were mock-infected with non-viruscontaining diluent. At 40 h post-infection (p.i.), culture medium was replaced with methionine-free medium with or without 1 ktg/ml tunicamycin and 2 h later L-[35S]methionine (1037 Ci/mmol; New England Nuclear) was added to a final concentration of 20 ~tCi/ml. After an additional 4 h incubation, cells were lysed in 0-5 ml of RIP buffer (Schlesinger et al., 1983) and lysates were cleared by centrifugation.
Immunoprecipitation was performed using a modification of previously described procedures (Wechsler et al., 1979) . Cell lysate (50 ktl) was incubated for 1.5 h at 4 °C with 5 ~tl of anti-YFV Asibi mouse immune ascitic fluid. A 1 : 1 slurry (30 #1) of Protein A-Sepharose CL-4B beads (Sigma) in RIP buffer was added and the mixture was incubated with gentle shaking at 25 °C for 1 h. The beads were washed four times with RIP buffer, resuspended in sample buffer (Laemmli, 1970) , boiled for 1 min, pelleted, and the supernatant was loaded onto a discontinuous, denaturing, 10% SDS-polyacrylamide gel (Laemmli, 1970) . Electrophoresis was performed at 150 V, after which the gel was infiltrated with En3Hance (New England Nuclear), dried, and autoradiographed.
Primers. Specific oligonucleotide primers, used in cDNA synthesis and hybridization screening of cDNA clones, were synthesized on an Applied Biosystems Model 380A DNA Synthesizer and were purified by polyacrylamide gel electrophoresis.
Cloning and sequencing, cDNA to YF 1899/81-B4.1 RNA was synthesized using reverse transcriptase and specific oligonucleotide primers and was cloned into plasmid pUC18 as previously described (Kinney et al., 1986) . Recombinant plasmids were screened for size and specificity by agarose gel electrophoresis and hybridization (Maniatis et al., 1982) . Appropriate cDNA fragments were subcloned into the The nucleotide sequence of the 1899/81-B4.1 strain was determined for a 3594 base region that included 108 nucleotides of the 5' non-coding region, the genes coding for the structural proteins [capsid (C), prM, envelope (E)], and all but the 72 T-terminal bases of the gene encoding the non-structural protein NS1. The 13 nucleotides at the 5' terminus of the genome were not determined. The sequence was determined for both strands of three overlapping cDNA clones. Fig. 1 shows an alignment of the partial nucleotide sequence of strain 1899/81-B4.1 with the corresponding region of the African Asibi strain (Hahn et al., 1987) . The distribution of the nucleotide differences between the two strains is summarized in Table 1 . Of the 515 changes, 406 were transitions and 109 were transversions. Nucleotide changes occurred throughout the region sequenced, but the degree of sequence divergence varied in different regions of the genome and within individual proteins, suggesting that certain domains require a higher degree of conservation to maintain function. Interestingly, 91.4% of the nucleotide changes in the coding region were silent, with only 45 of 512 nucleotide changes resulting in amino acid changes. One of the amino acid substitutions resulted from the combination of two nucleotide changes in a single codon. Of the 467 silent nucleotide changes, 433 were in the third base of the codon. Codon usage and CG doublet frequency were similar to that found in the Asibi genome. The nucleotide sequence of the 5' untranslated region of the genome is highly conserved among YFV strains (Hahn et al., 1987) . We observed a significantly lower percentage change in this region (2-8~o) than in the coding region (14.7~). Mutations in untranslated regions may affect gene expression by changing the secondary structure of the RNA or by altering regulatory sequences that influence transcription or translation. Ruiz-Linares et al. (1989) found that changes in the YFV 5" non-coding region that increased secondary structure decreased the translational efficiency of downstream genes. Gene expression was also affected by interactions between the 5' untranslated sequence and coding regions (Ruiz-Linares et al., 1989) .
Deduced amino acid sequence
The deduced sequence of the amino-terminal 1162 amino acids of the translated polyprotein precursor of strain 1899/8 I-B4.1 is aligned with the corresponding region of the Asibi and 17D strains in Fig. 2 . Cysteine residues and proposed sites for cleavage of the polyprotein were conserved, and the hydropathic profiles of the three YFV strains were nearly identical (data not shown). Table 1 summarizes the amino acid differences that were detected between the 1899/81 and Asibi YFV strains. Overall there were 44 amino acid differences, over "17~ of which were conservative in nature, distributed in a non-random fashion throughout the region.
The highest rate of divergence occurred in the capsid protein (6.7~) where eight amino acid differences were found. However, seven of these were conservative and the basic character of the protein, which may be involved in packaging of the viral RNA into the nucleocapsid (Rice et al., 1985) , was conserved. One non-conservative substitution (His-102 to Tyr) was found near the carboxyl terminus of the protein.
Three amino acid differences occurred between the prM regions of strains 1899/81 and Asibi; two nonconservative substitutions in the portion cleaved from the precursor protein (Ash-7 to Ser and Tyr-39 to Asn) and a single hydropathically conservative change in the putative membrane-spanning region (Rice et al., 1985) of the mature M protein (Thr-48 to Ala). The M protein was the most highly conserved at the amino acid level (1.3 change) although this gene showed the most nucleotide variation (16~ change).
Many of the phenotypic differences between African and American YFV strains may be attributable to changes in the E protein. The flavivirus envelope protein has been the subject of recent studies that have begun to elucidate its structure and functions. Immunochemical analyses utilizing monoclonal antibodies (Schlesinger et al., 1983; Heinz, 1986; Roehrig, 1986) have identified domains of functional significance and various structural models have been proposed based on analyses of hydrophobicity, predicted secondary structure and disulphide linkages (Nowak & Wengler, 1987; Roehrig et al 1989; Mandl et al., 1989) . In each of these models, antigenic domains have been identified that are composed of discontinuous regions of the protein brought together by secondary folding of the molecule. As the secondary and three-dimensional structure of the E protein is refined, functional consequences of amino acid substitutions in the primary sequence of the polypeptide may be interpreted more reliably.
The E proteins of YFV strains Asibi and 1899/81 differed by 18 amino acids. Five of these differences were non-conservative (Asn-62 to Ser, Asp-270 to Gly, Asn-271 to Ser, Pro-390 to His and Asn-450 to Ser). Thirteen of the changes occurred in the carboxyl half of the protein, with a cluster of six changes between positions 318 and 360. Interestingly, the E proteins of the 1899/81 and 17D strains shared two amino acid differences relative to the E protein of the Asibi strain, a conservative Lys-331 to Arg substitution and the nonconservative change from Pro-390 to His. The latter is a potentially significant difference that may affect the structure of the protein. No differences were observed in the flavivirus-conserved region near the amino terminus of the E protein (Asp-98 to Gly-111). Three differences were detected in the region from Pro-369 to Gly-448, which also is highly conserved among flaviviruses, two of which resulted in the same amino acid residue that is present at equivalent positions in most other flaviviruses. The first was the Pro-390 to His substitution mentioned above; His is also present at the equivalent position in Murray Valley encephalitis, St Louis encephalitis, West Nile, Kunjin and Japanese encephalitis viruses. Dengue and tick-borne encephalitis (TBE) viruses have a Phe at this position. The second was an Ala residue present in YFV 1899/8l and all other sequenced flaviviruses, except TBE virus (Ile), in place of the Val-407 found in the YFV Asibi strain.
The E protein of certain African and American YFV strains has been shown to differ in electrophoretic mobility and carbohydrate content indicating differences in glycosylation of the E protein between these populations. Specifically, electrophoresis of viral proteins from infected cells shows that African YFV strains produce a single, non-glycosylated form of E protein whereas American strains produce two forms, one of which is glycosylated (Deubel et al., 1987; Cane & Gould, 1989 5) . In the deduced amino acid sequence of YFV 1899/81-B4.1 the two potential glycosylation sites (Asn-X-Ser/Thr) present in the African YF E protein (Hahn et al., 1987) were conserved. However, the S. American strain contained an additional site as a result of the Asn-271 to Ser substitution mentioned above. The larger (65K) form of the E protein in S. American YFV strains may be due to the presence of the additional N-linked glycosylation site at position E-269 (Fig. 2 ) resulting in increased carbohydrate content. However, as two forms of the E protein are also present in lysates of YFV 17D-infected cells (Schlesinger et al., 1983) , although this strain lacks the additional E-269 site (Rice et al., 1985) , glycosylation may be influenced by other sequence changes in the region as well. The structurally significant change from Pro-390 in the Asibi strain to His in the 1899/81 and 17D strains may affect glycosylation by altering the conformation of this region of the E protein (Hahn et al., 1987) . Thus, variation in the carbohydrate content of the E protein in different YFV strains may result from a combination of factors. The NS1 proteins of the YFV 1899/81 and Asibi strains differed to the same extent as the E proteins (Table 1) , in contrast to the sequence comparison between the Asibi and 17D YFV strains where the NS1 amino acid sequence was significantly more conserved than the E protein sequence (Hahn et al., 1987) . Fifteen amino acid differences were detected in the sequenced region of the NS1 protein, 10 of which occurred in the carboxyl one third of the protein. Two of these changes were hydropathically non-conservative (Asn-290 to Gly and Ser-343 to Asn). Since the function of the NS1 protein remains unclear, it is difficult to speculate on the significance of the differences observed in this region.
The determination of viral sequences is a prerequisite to analysing the molecular biology of viruses and investigating the molecular basis for characteristic differences between related virus strains. The biological and physical differences between YFV strains from Africa and the Americas suggest that a significant amount of evolutionary divergence has occurred. In this study we have shown that many nucleotide sequence differences exist between representative strains of these populations yet the strains remain remarkably similar at the amino acid level. Further work with a controllable model, such as an infectious cDNA clone, may be required before the biological significance of individual sequence differences can be determined.
